World's Best Scientists 2026 revealed!
Award Badge
Medicine
France
2023

D-Index & Metrics

Medicine

D-Index
155
Citations
103762
World Ranking
946
National Ranking
23

Research.com Recognitions

  • 2023 - Research.com Medicine in France Leader Award

Overview

Pierre Fenaux is affiliated with Université Paris Cité in France and has an extensive publication record in the field of medicine, with a particular focus on hematology. Their research spans several subfields including hematology, genetics, molecular biology, rheumatology, and oncology.

The scientist's work prominently addresses topics such as acute myeloid leukemia research, myeloproliferative neoplasms with an emphasis on diagnosis and treatment, hemoglobinopathies and related disorders, chronic myeloid leukemia treatments, otitis media and relapsing polychondritis, histone deacetylase inhibitors research, and hematopoietic stem cell transplantation.

Frequent publication venues include Blood, Clinical Lymphoma Myeloma & Leukemia, Leukemia, Journal of Clinical Oncology, and HemaSphere.

Key recent papers authored or co-authored by Pierre Fenaux are:

  • "Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN," 2022, Blood
  • "Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia," 2020, New England Journal of Medicine
  • "Molecular International Prognostic Scoring System for Myelodysplastic Syndromes," 2022, NEJM Evidence
  • "Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes," 2020, Nature Medicine
  • "Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes," 2020, New England Journal of Medicine

Pierre Fenaux has collaborated frequently with researchers such as Uwe Platzbecker, Valeria Santini, Lionel Adès, Rami S. Komrokji, and Amer M. Zeidan.

Best Publications

  • Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

    Hartmut Döhner;Elihu Estey;David Grimwade;Sergio Amadori

  • Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

    Hartmut Dohner;Elihu H. Estey;Sergio Amadori;Frederick R. Appelbaum

  • Revised International Prognostic Scoring System for Myelodysplastic Syndromes

    Peter L. Greenberg;Heinz Tuechler;Julie Schanz;Guillermo Sanz

  • Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.

    Pierre Fenaux;Ghulam J. Mufti;Eva Hellstrom-Lindberg;Valeria Santini

  • Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

    Courtney D DiNardo;Brian A Jonas;Vinod Pullarkat;Michael J Thirman

  • All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results.

    Sylvie Castaigne;Christine Chomienne;Marie Therese Daniel;Paola Ballerini

  • Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia

    Pierre Fenaux;Ghulam J. Mufti;Eva Hellström-Lindberg;Valeria Santini

  • A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

    Pierre Fenaux;Claude Chastang;Sylvie Chevret;Miguel Sanz

  • Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

    Sylvie Castaigne;Cécile Pautas;Christine Terré;Emmanuel Raffoux

  • p53 Mutations Are Associated With Resistance to Chemotherapy and Short Survival in Hematologic Malignancies

    Eric Wattel;Claude Preudhomme;Bernard Hecquet;Michael Vanrumbeke

  • Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

    Luca Malcovati;Eva Hellström-Lindberg;David Bowen;Lionel Adès

  • Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment

    Catherine Roche-Lestienne;Valerie Soenen-Cornu;Nathalie Grardel-Duflos;Jean-Luc Laı̈

  • Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera

    Jean-Jacques Kiladjian;Bruno Cassinat;Sylvie Chevret;Pascal Turlure

  • OUTCOME OF TREATMENT IN ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: ANALYSIS OF THE LALA-94 TRIAL

    Xavier Thomas;Jean Michel Boiron;Françoise Huguet;Hervé Dombret

  • Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group

    P Fenaux;MC Le Deley;S Castaigne;E Archimbaud

  • Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA).

    Claude Preudhomme;Christophe Sagot;Nicolas Boissel;Jean-Michel Cayuela

  • Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System.

    Hagop Kantarjian;Susan O'Brien;Farhad Ravandi;Jorge Cortes

  • Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

    R Itzykson;O Kosmider;T Cluzeau;V Mansat-De Mas

  • Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia

    Raphaël Itzykson;Olivier Kosmider;Aline Renneville;Véronique Gelsi-Boyer

  • Bibliography International scoring system for evaluating prognosis in myelodysplastic syndromes.

    Greenberg P;Cox C;Fenaux P;Morel P

Frequent Co-Authors

Claude Preudhomme
Claude Preudhomme University of Lille
Christine Chomienne
Christine Chomienne Université Paris Cité
Hervé Dombret
Hervé Dombret Université Paris Cité
Ghulam J. Mufti
Ghulam J. Mufti King's College London
Emmanuel Raffoux
Emmanuel Raffoux Hôpital Saint-Louis
Eva Hellström-Lindberg
Eva Hellström-Lindberg Karolinska University Hospital
Guillermo Sanz
Guillermo Sanz Hospital Universitari i Politècnic La Fe
Mikkael A. Sekeres
Mikkael A. Sekeres Cleveland Clinic
Alan F. List
Alan F. List Precision BioSciences
Lionel Ades
Lionel Ades Aplastic Anemia and MDS International Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in healthcare but want alternatives to the traditional MD pathway? There are several flexible and accessible online degree options available. For those interested in nursing, many easiest rn program options provide smoother entry points into the field and can be completed fully online.

If you prefer administrative roles, a healthcare administration associate degree online offers a fast track into healthcare management positions—often with accelerated programs and flexible schedules.

Medical billing and coding is another rewarding path that offers strong remote job prospects. Many schools provide financial aid for medical billing and coding, helping students reduce out-of-pocket expenses as they train for these in-demand careers.

Aspiring Licensed Practical Nurses (LPNs) can look for accessible options, including an lpn program without teas test requirements, streamlining admission.

These varied pathways allow you to build a career in healthcare, even if the traditional route to an MD isn’t right for you.

Best Scientists Citing Pierre Fenaux

Trending Scientists